Clinical Trials Directory

Trials / Completed

CompletedNCT02703870

Combined tDCS and Vision Restoration Training in Post-acute Stroke: an Exploratory Efficacy and Safety Study

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
19 (actual)
Sponsor
University of Magdeburg · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this Study is to determine whether non-invasive transcranial direct current stimulation (tDCS) is effective in increasing rehabilitation effects after stroke in visual Cortex.

Detailed description

Visual field defects after posterior cerebral artery stroke can be improved by vision restoration training (VRT), but when combined with transcranial direct current stimulation (tDCS) which alters brain excitability, vision restoration can be potentiated in the chronic stage. Because it is possible that such therapy may be more effective during the early recovery phase after the stroke and can reach patients during the rehabilitation phase, investigators wished to explore the applicability, efficacy and safety of early intervention with a combined tDCS/VRT treatment. 19 post-acute stroke homonymous hemianopia patients were randomly assigned to either 10 sessions of combined rea-tDCS (2mA, 10 daily sessions of 15-20 min) and VRT, or sham-tDCS and VRT. The primary outcome criterion was the pre-post change in perimetric detection thresholds. Secondary outcome is neurophysiological changes in EEG measures (VEP, Connectivity, Spectral Power, ...)

Conditions

Interventions

TypeNameDescription
DEVICEverum tDCSreal transcranial direct current stimulation,10 sessions, 2mA for 20 minutes
DEVICEsham tDCSsham transcranial direct current stimulation, 10 sessions, for 20 minutes
BEHAVIORALVRTVision restoration training, 10 sessions, 20 minutes

Timeline

Start date
2013-03-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2016-03-09
Last updated
2016-03-09

Locations

2 sites across 2 countries: Austria, Germany

Source: ClinicalTrials.gov record NCT02703870. Inclusion in this directory is not an endorsement.